HYPD (HYPD) Stock Price & Analysis
HYPD (HYPD) rose 0.00% to USD 3.3 as of September 8, 2026 at 08:18 UTC, according to Nexqual real-time market data.
HYPD last closed at USD 3.3; the session ranged USD 3.21–3.35 on volume of 321,954 shares. Market capitalization is —, with a 52-week range of USD 2.34–15 (NCM). Source: Nexqual, September 8, 2026 at 08:18 UTC.
Key Statistics (as of September 8, 2026 at 08:18 UTC)
| Price | USD 3.3 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 3.3 |
| Open | USD 3.3 |
| Day Range | USD 3.21 – 3.35 |
| 52-Week Range | USD 2.34 – 15 |
| Volume | 321,954 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (HYPD)
Nexqual's technical model rates HYPD "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 08:18 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 56.72 (neutral) |
| vs SMA50 | Above (USD 2.93) |
| MACD | 0.12 (positive) |
From HYPD's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CYPH | Cypherpunk Technologies Inc. | USD 2.42 | ▲ 44.05% |
| CRVS | Corvus Pharmaceuticals, Inc. | USD 14.39 | ▲ 1.34% |
| ADIL | Adial Pharmaceuticals, Inc | USD 7.12 | ▲ 12.66% |
| KZIA | Kazia Therapeutics Limited | USD 12.31 | ▼ 2.38% |
| MBIO | Mustang Bio, Inc. | USD 0.54 | ▼ 0.02% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:18 UTC. This page is informational and not investment advice.